Acadia Pharmaceuticals | ACAD - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
ALKERMES USD 375.31M 43.98M 2026-06
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Cytokinetics USD 23.03M 3.84M 2026-06
Eisai JPY 183.24B 29.83B 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Incyte USD 1.57B 400.89M 2026-06
J&J USD 18.55B 1.31B 2026-06
Moderna USD -566M 792M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Pfizer USD -248M 11.29B 2026-06
Prothena USD 51.08M 51.06M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06